Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Exam Prep1
- Article Type
- Clinical Trial1
- Clinical Study1
- Research Support, U.S. Gov't, P.H.S.1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Cancer Treat Rep1
Search Results
Sort by
- BookMatthew L. Carlson, Kathryn M. Van Abel, David J. Archibald, Daniel L. Price.Summary: "This publication will provide residents and practicing otolaryngologists a well-organized and concise resource for rapid examination review. It contains succinct and high-yield facts using simple one to two phrase questions and answers. Over 9,100 Q & A are included, half in the book and half online as part of WinkingSkull.com. We will include drawings to illustrate important points when needed. Chapters will be divided based on the various subspecialties in the field (rhinology, facial plastics, otology etc)"--Provided by publisher.Digital Access Thieme MedOne Otolaryngology 2015
- ArticleBruckner HW, Cohen CJ, Wallach RC, Kabakow B, Deppe G, Greenspan EM, Gusberg SB, Holland JF.Cancer Treat Rep. 1978 Apr;62(4):555-8.Nineteen patients with advanced ovarian adenocarcinoma were treated with cis-dichlorodiammineplatinum(II) (DDP), 50 mg/m2 as an iv bolus once every 3 weeks. Prior treatment had exhausted other chemotherapeutic options or damaged the bone marrow sufficiently to contra-indicate treatment with standard drugs. All patients had evaluable tumors and evidence of failure of prior therapy. DDP produced objective responses, relieved symptoms due to tumor, and improved the patients' quality of survival. There were no serious hematologic complications due to therapy except anemia.